Cargando…

SARS vaccine to receive funding in the US

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2013
Materias:	News Item
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141170/ http://dx.doi.org/10.1007/BF03276914

Ejemplares similares

SARS vaccine to receive funding in the US
Publicado: (2013)

US-labelled supply of Moderna's COVID-19 vaccine in Cananda
Publicado: (2021)

Reliable SARS diagnostic only weeks away, says US CDC
Publicado: (2013)

Four vaccine manufacturers have been asked by the US HHS to test their vaccines against coronavirus,
Publicado: (2013)

NZ's Pharmac to fund baricitinib for moderate-to-severe COVID-19
Publicado: (2021)

NZ's Pharmac to fund tocilizumab for moderate-to-severe cases of COVID-19
Publicado: (2021)

COVID-19 vaccine and influenza vaccine mix-ups
Publicado: (2021)

SARS testing underway
Publicado: (2013)

SARS preparations stepped up worldwide
Publicado: (2013)

Can we meet the challenge of SARS?
Publicado: (2013)

Pfizer-BioNTech COVID-19 vaccine: AEs after vaccination in New Zealand
Publicado: (2021)

COVID-19 vaccine safety monitoring
Publicado: (2021)

No safety concerns with Comirnaty vaccine in pregnancy
Publicado: (2021)

COVID-19 vaccination encouraged by the EMA/ECDC
Publicado: (2021)

Cutaneous vasculitis following COVID-19 vaccination
Publicado: (2021)

Myocarditis, pericarditis with COVID-19 vaccines in the Netherlands
Publicado: (2021)

Myocarditis or pericarditis following COVID-19 vaccination
Publicado: (2021)

Myocarditis and pericarditis after COVID-19 vaccination
Publicado: (2021)

COVID-19 vaccination and risk of neuralgic amyotrophy
Publicado: (2022)

Flu vaccine associated with nine deaths in Japan this year
Publicado: (2013)

EMA's safety monitoring plan for COVID-19 vaccines
Publicado: (2020)

ISMP reports: errors or hazards with COVID-19 vaccines
Publicado: (2021)

Advice on COVID-19 vaccines approved in UK by MHRA
Publicado: (2021)

Tozinameran vaccination in Canada: no change in benefit-risk profile
Publicado: (2021)

Second HPRA safety update on COVID-19 vaccines
Publicado: (2021)

AstraZeneca COVID-19 vaccine: thrombosis with thrombocytopenia
Publicado: (2021)

Falsified COVID-19 vaccine recently identified in Mexico
Publicado: (2021)

Anaphylaxis in Australia with AstraZeneca's COVID-19 vaccine
Publicado: (2021)

Product monographs for COVID-19 vaccines updated in Canada
Publicado: (2021)

No association between COVID-19 vaccination and menstrual disorders
Publicado: (2021)

Janssen COVID-19 vaccine-related tinnitus and dizziness
Publicado: (2021)

PMDA: precautions should be revised for Covid-19 vaccine
Publicado: (2021)

Possibility of mix-up with paediatric COVID-19 vaccines
Publicado: (2021)

Shoulder pain and inflammation after vaccination in upper arm
Publicado: (2022)

PRAC: blood clots with Janssen's COVID-19 vaccine
Publicado: (2021)

COVID-19 vaccination errors in USA reported to ISMP
Publicado: (2021)

Myocarditis, pericarditis included in labelling for two COVID vaccines
Publicado: (2021)

Bleeding and clotting with AstraZeneca's COVID-19 vaccine
Publicado: (2021)

Signal for COVID-19 vaccine-related menstrual disorders
Publicado: (2022)

COVID-19 vaccine-induced VITT/TSS in Malaysia
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vqc4j09857ee1abisjgf5d3pvn